DATE: Tuesday, March 10, 2015 TIME: 09:00 PST, 11:00 CST, 12:00 EST, 16:00 GMT
The International Myeloma Working Group (IMWG) has issued updated criteria for the diagnosis of multiple myeloma.
The updated criteria, published in The Lancet Oncology represent a significant change in how Multiple Myeloma is diagnosed and the stage at which patients should be treated.
Join us on March 10th on a webinar covering these updated criteria for Myeloma and related plasma cell disorders and the importance of biomarkers in Early Stage Disease. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Following this presentation the listener will: • Understand the history and traditional tools used to diagnose Myeloma • Gain an appreciation for the evolution of Myeloma diagnosis and biomarkers of the disease • Be able to understand how to apply the new diagnostic guidelines to the diagnosis and treatment of Myeloma.